DETAILED NOTES ON SIRPIGLENASTAT CLINICAL TRIAL

“This certain prodrug style produced DON qualified to its meant spot (tumor) and also have considerably less of an influence on balanced cells somewhere else.”It has anticancer consequences by straight targeting tumor metabolism and at the same time inducing a powerful antitumor immune reaction with immunomodulatory and antineoplastic functions